SCHEMBL15028495

SCHEMBL15028495

CCCCO[C@@H]1OC2COC(C)(C)O[C@H]2C(O[C@@H]2OC(COC(C)=O)[C@H](OC(C)=O)C(OC(C)=O)[C@@H]2OC(C)=O)[C@@H]1NC(=O)C(Cl)(Cl)Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ LMNA P02545 3/20 0.36
▸ CYP2D6 P10635 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ POLB P06746 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CA12 O43570 10/20 0.34
▸ CA1 P00915 10/20 0.34
▸ CA2 P00918 10/20 0.34
▸ CA9 Q16790 10/20 0.34
▸ CA14 Q9ULX7 4/20 0.34
▸ KMT2A Q03164 1/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16156440 0.94 CYP3A4 (0.35) CYP3A4MAPTCYP2C9CYP2C19LMNA
SCHEMBL15028542 0.92 CYP3A4 (0.43) CYP3A4MAPTCYP2C9CYP2C19LMNA
SCHEMBL15028640 0.90 CYP3A4 (0.38) CYP3A4MAPTCYP2C9CYP2C19LMNA
SCHEMBL16153925 0.80 LMNA (0.45) CYP3A4MAPTCYP2C9CYP2C19LMNA
SCHEMBL15028500 0.80 LMNA (0.45) CYP3A4MAPTCYP2C9CYP2C19LMNA
SCHEMBL15028490 0.78 ALDH1A1 (0.37) CYP3A4MAPTCYP2C9CYP2C19LMNA
SCHEMBL2804057 0.74 — —
SCHEMBL15028629 0.73 MAPK1 (0.55) THRBALDH1A1KMT2A
SCHEMBL15028637 0.73 MAPK1 (0.57) CYP3A4MAPTCYP2C9CYP2C19LMNA
SCHEMBL15508135 0.72 CYP3A4 (0.60) CYP3A4MAPTCYP2C9CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013083136-A1 PREPARATION AND USE OF ISOLACTOSAMINE AND INTERMEDIATES THEREFOR GLYCOM A/S (DK) 2013-06-13 — — WO disclosed
Send feedback